Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Librium 5mg Capsules.
| Pharmaceutical Form |
|---|
|
Librium Capsules 5 mg. |
Each 5mg capsule contains 5mg of the active ingredient chlordiazepoxide hydrochloride BP.
Each capsule contains 105.9 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Chlordiazepoxide |
Chlordiazepoxide has anxiolytic and central muscle relaxant properties. It has little autonomic activity. Chlordiazepoxide acts as depressant of the central nervous system producing all levels of CNS depression, from mild sedation to hypnosis, to coma depending on the dose. |
| List of Excipients |
|---|
|
5mg capsules contain the following excipients: Gelatine |
PVDC Blister pack container 10 capsules.
HDPE bottle with jay-cap (snap-fit) closure containing 100 capsules.
Plastic bottle with screw cap containing 100 capsules.
Amber glass bottle with screw cap containing 100 capsules.
Not all pack sizes may be marketed.
Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
PL 46302/0175
1 March 1998 / 18 March 2003
| Drug | Countries | |
|---|---|---|
| LIBRIUM | Germany, Ireland, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
